Castle Biosciences Inc Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -6.37M5.28M-10.28M-31.29M-67.14M-57.47M18.25M
Depreciation and Depletion 0.29M0.35M0.47M1.45M2.28M3.32M4.89M
Share-based Compensation 0.29M1.25M8.31M21.74M36.32M51.22M50.32M
Deferred Taxes -8.74M-1.88M-0.22M1.40M
Gains from Investment Securities 0.27M0.62M0.10M2.89M-18.29M5.13M8.76M
Cash from Operations -12.29M7.01M9.87M-18.98M-41.66M-5.63M64.87M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.04M0.00M1.37M5.49M6.68M
Amortization of Deferred Charges 0.57M1.93M0.84M
Depreciation & Amortization (CF) 0.29M0.35M0.47M3.41M10.54M12.33M16.00M
Change in Working Capital
Change in Receivables 8.41M0.90M-1.66M4.63M6.22M14.93M12.64M
Change in Inventory 0.58M0.35M0.98M-0.33M1.68M3.96M0.19M
Change in Account Payables 0.20M0.56M0.17M-0.18M0.58M5.71M-4.37M
Change in Accured Expenses 1.35M1.21M3.33M6.21M8.49M4.59M3.61M
Other Working Capital Changes 0.16M1.28M8.35M-8.35M1.22M0.85M-1.29M
Investing Activities
Capital Expenditures 0.28M0.94M4.75M3.48M5.63M13.62M28.33M
Sales of Property, Plant and Equipment 0.00M0.01M0.20M0.01M0.02M
Acquisitions 26.97M
Change in Acquisitions & Divestments 186.50M183.90M
Cash from Investing Activities -0.28M-0.94M-4.75M-66.66M-166.54M-16.18M-50.14M
Financing Activities
Other financing activities 0.34M
Cash from Financing Activities 15.84M88.29M305.89M5.42M1.51M-2.30M6.14M
Additional items
Change in Cash 3.27M94.37M311.01M-80.22M-206.69M-24.11M20.87M
Free Cash Flow -12.57M6.08M5.11M-22.47M-47.29M-19.25M36.54M
Net Cash Flow 3.27M94.37M311.01M-80.22M-206.69M-24.11M20.87M